Latest Hemant Surgical Industries stock price
Hemant Surgical Industries P/E Ratio
HSIL • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
44.96
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
44.96
Current Price
₹
EPS (TTM)
₹7.70
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
53.46
Sector Median
30.38
Sector Rank
#11 of 131
Sector Percentile
8.4%
Key P/E Ratio Insights for Hemant Surgical Industries
- Stock appears overvalued with PE of 44.96, suggesting caution for new investments
- Trading at discount to sector average PE of 53.46
View the HSIL equity price for detailed stock performance.
Related Pages for Hemant Surgical Industries
Additional stock information and data for HSIL
Sector P/E Ratio Comparison
Comparing Hemant Surgical Industries with other companies in Healthcare sector
Sector Average
53.46
Sector Median
30.38
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |